Federal contract award
75A50120F33001
CLINICAL TRIALS PLANNING AND EXECUTION PHARM-OLAM BASE TO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75A50120D00016 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $42.1K |
| Current contract value | $42.1K |
| Potential contract value / ceiling | $42.1K |
| Start date | Sep 28, 2020 |
| Current end date | Sep 27, 2021 |
| Potential end date | Sep 27, 2021 |
| Latest award activity | Sep 11, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 11, 2025 | P00002 | $-157.9K | CLINICAL TRIALS PLANNING AND EXECUTION PHARM-OLAM BASE TO |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.